Puma Biotechnology, Inc. (PBYI)
7.055
+0.20
(+2.99%)
USD |
NASDAQ |
Jun 09, 16:00
7.055
0.00 (0.00%)
After-Hours: 17:40
Puma Biotechnology Shareholders Equity (Quarterly) : 128.42M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -217.14M |
| AbbVie, Inc. | -6.656B |
| Agios Pharmaceuticals, Inc. | 1.109B |
| UroGen Pharma Ltd. | -124.25M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.70M |
| Total Liabilities (Quarterly) | 64.28M |
| Debt to Equity Ratio | 0.1242 |
| Current Ratio | 2.381 |
| Net Debt Paydown Yield | 3.58% |